Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Cj Bioscience Inc. is managing 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct art units for the company patent portfolio. The prosecution involves 4 distinct examiners, which matches the total number of 4 pending office actions. This alignment of examiners and pending actions means that each matter is being evaluated by a different official within the patent office.
CRUM, MARY ABOU NADER is the busiest examiner for the portfolio, currently overseeing 1 pending office action. Since there are 4 distinct examiners for the pending office actions, the workload is spread so that each examiner handles exactly 1 action. This distribution across the 3 distinct art units indicates that the 4 pending office actions are being processed by different individuals. Practitioners must navigate the specific requirements of the distinct examiners while managing the portfolio's presence in the Biotechnology & Pharmaceuticals sector. The 4 pending office actions are the only current matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §112 only | 1 (25%) |
| Double-patenting + other | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CRUM, MARY ABOU NADER | 1 | 40.4% | +65.0% |
| ARIANI, KADE | 1 | 74.9% | +32.4% |
| DICKENS, AMELIA NICOLE | 1 | 47.6% | +21.1% |
| STEPHENS, AMELIA CAROLE | 1 | 85.7% | +33.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18028913 | COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM | STEPHENS, AMELIA CAROLE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18711372 | NOVEL LEUCONOSTOC MESENTEROIDES STRAIN | CRUM, MARY ABOU NADER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18711372 | NOVEL LEUCONOSTOC MESENTEROIDES STRAIN | CRUM, MARY ABOU NADER | — |
| 18705390 | COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING INFLAMMATORY SKIN DISEASES, COMPRISING CUTIBACTERIUM SP. STRAIN | ARIANI, KADE | — |
| 18704774 | COSMETIC COMPOSITION FOR PREVENTION OR IMPROVEMENT OF INFLAMMATORY SKIN DISEASES COMPRISING STRAIN OF GENUS CUTIBACTERIUM | DICKENS, AMELIA NICOLE | — |
| 18028913 | COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM | STEPHENS, AMELIA CAROLE | — |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 1657 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18711372 | NOVEL LEUCONOSTOC MESENTEROIDES STRAIN | CRUM, MARY ABOU NADER | 1657 | §101§112DP | Non-Final OA | — | Pending | May 17, 2024 |
| 18705390 | COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING INFLAMMATORY SKIN DISEASES, COMPRISING CUTIBACTERIUM SP. STRAIN | ARIANI, KADE | 1651 | §112DP | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18704774 | COSMETIC COMPOSITION FOR PREVENTION OR IMPROVEMENT OF INFLAMMATORY SKIN DISEASES COMPRISING STRAIN OF GENUS CUTIBACTERIUM | DICKENS, AMELIA NICOLE | 1645 | §102§103§112DP | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18028913 | COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM | STEPHENS, AMELIA CAROLE | 1645 | §112 | Non-Final OA | — | Pending | Mar 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial